Background: Development of the epidermal permeability barrier (EPB) is essential for neonatal life. Defects in this barrier are found in many skin diseases such as atopic dermatitis. oBjective: We investigated the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the development and function of the EPB. Methods: Timed-pregnant C57BL/6J mice were gavaged with corn oil or TCDD (10 μg/kg body weight) on gestation day 12. Embryos were harvested on embryonic day (E) 15, E16, E17, and postnatal day (PND) 1. results: A skin permeability assay showed that TCDD accelerated the development of the EPB, beginning at E15. This was accompanied by a significant decrease in transepidermal water loss (TEWL), enhanced stratification, and formation of the stratum corneum (SC). The levels of several ceramides were significantly increased at E15 and E16. PND1 histology revealed TCDD-induced acanthosis and epidermal hyperkeratosis. This was accompanied by disrupted epidermal tight junction (TJ) function, with increased dye leakage at the terminal claudin-1-staining TJs of the stratum granulosum. Because the animals did not have enhanced rates of TEWL, a commonly observed phenotype in animals with TJ defects, we performed tape-stripping. Removal of most of the SC resulted in a significant increase in TEWL in TCDD-exposed PND1 pups compared with their control group. conclusions: These findings demonstrate that in utero exposure to TCDD accelerates the formation of an abnormal EPB with leaky TJs, warranting further study of environmental exposures, epithelial TJ integrity, and atopic disease. 
Introduction
Formation of a competent epidermal permea bility barrier (EPB) is essential to terrestrial life. This barrier prevents desiccation and protects the body against microbes, as well as physical and chemical insults. The EPB is established in utero during embryonic devel opment and maintained throughout life. In humans, EPB formation occurs between 20 and 24 weeks of gestation (Hardman et al. 1999) . Barrier formation in mice starts at embryonic day (E) 16 and is completed by E17.5 (Hardman et al. 1998) . The stratum corneum (SC), the outermost layer of the epidermis, contributes greatly to the func tioning of the EPB. The SC is made up of corneocytes: terminally differentiated keratinocytes, highly crosslinked by trans glutaminases with cornified envelope proteins such as loricrin, involucrin, filaggrin, and small prolinerich proteins. These anucle ated cells are embedded in a lipid matrix of ceramides, cholesterol, and free fatty acids to form the "brick and mortar" structure of the SC that seals the epidermis and provides protection to the skin (Menon et al. 2012) .
In addition to the SC, tight junctions (TJs) provide additional barrier function to the skin. TJs are distributed in the stratum granulosum (SG) layer, located beneath the SC. TJs seal the intercellular spaces between cells and regulate paracellular transport of water, ions, and solutes (Proksch et al. 2008) . Several studies have demonstrated that the EPB is compromised in mice that have disrupted TJs (Furuse et al. 2002; Turksen and Troy 2002) . A defective EPB (Boguniewicz and Leung 2011; De Benedetto et al. 2012; Proksch et al. 2008 ) and decreased expression of TJ proteins have been reported in patients with atopic dermatitis (De Benedetto et al. 2011 ) and psoriasis (Kirschner et al. 2010) . A claudin1 defi ciency has been associated with NISCH syndrome (neonatal ichthyosissclerosing cholangitis, a familial form of ichthyosis) (Morita et al. 2011) . Disruption of epithe lial TJ function also has been reported in the lungs of patients with asthma (Xiao et al. 2011) and in the intestines of people with inflammatory bowel diseases (Schulzke et al. 2009 ).
2,3,7,8Tetrachlorodibenzopdioxin (TCDD) is a ubiquitous environmental pollutant and the most potent aryl hydro carbon receptor (AHR) ligand. The hallmark of TCDD toxicity in humans is chloracne (Panteleyev and Bickers 2006) , characterized by epidermal acanthosis and hyperkeratosis, and hyperkeratinization and metaplasia of the sebaceous glands, with comedone formation. In cultures of normal human epidermal kera tinocytes, treatment with TCDD increased the expression of many genes involved in cornification and EPB formation (Kennedy et al. 2013; Sutter et al. 2009 Sutter et al. , 2011 , leading to enhanced rates of terminal differentiation (Sutter et al. 2009 ) and ceramide biosynthesis (Kennedy et al. 2013) . In organotypic culture of a normal human keratinocyte cell line, TCDD has been reported to cause early onset of terminal differentiation, and pre mature and irregular expression of filaggrin and involucrin, with marked thickening of the keratinized cell layers and hyperkeratosis (Loertscher et al. 2001) .
In haired rodents, chloracnelike skin lesions are usually absent after TCDD treatment; although in one study of B6C3F1 mice, such lesions were observed after 2 years of treatment with the dioxinlike compound 3,3´,4,4´tetrachlorazobenzene (Ramot et al. 2009 ). Compared with haired mice, hairless mouse strains (hr/hr mutants) are very sensitive to TCDDinduced lesions characteristic of chloracne, including epidermal hyperplasia and hyperkeratiniza tion and involution of the sebaceous glands (Puhvel and Sakamoto 1988) . Studies of in utero exposure of C57BL/6J embryos to TCDD by gavage of the dam showed acceler ated expression of filaggrin at E16 and the presence of a morphologically wellorganized epidermis in these TCDDexposed embryos (Loertscher et al. 2002) . In a subsequent study, we reported that in utero-exposed C57BL/6J mouse embryos exhibited accel erated formation of the EPB by 1 day, and that in normal human keratino cytes, many of the genes of the epidermal differentiation complex responded to TCDD (Sutter et al. 2011) . Of particular interest, filaggrin gene expression was shown to be directly regulated by AHRbinding to the filaggrin xenobiotic response element in response to TCDD (Sutter et al. 2011) . Because of the emerging association between disrupted EPB function and inflammatory diseases of the skin, we performed studies to determine whether the acceleration of the EPB by in utero exposure to TCDD resulted in normal or abnormal structure and function of the EPB.
Materials and Methods
Animals. We purchased timemated, presumedpregnant C57BL/6J mice from Jackson Laboratory (Bar Harbor, ME), defining E1 as the day after a vaginal plug was observed. We housed two to five dams in clear plastic cages and maintained a 12:12hr light:dark cycle in a temperaturecontrolled room (24°C ± 1°C) with 35% ± 4% relative humidity, providing food and water to the mice ad libitum. Pregnant dams were eutha nized by asphyxiation with carbon dioxide, and the entire uterus with embryos was removed. We dissected the embryos from the embryonic sacs and rinsed them twice in icecold (4°C) phosphate buffered saline (PBS), pH 7.4. Postnatal day (PND) 1 pups were euthanized by intraperitoneal injec tion of SOMNASOL TM EuthanasiaIII solution (1 mL/4.5 kg body weight; National Drug Code no. 1169548291; Butler Schein Animal Health, Dublin, OH). Animal research protocols were approved by the University of Memphis Institutional Animal Care and Use Committee; animals were treated humanely and with regard for alleviation of suffering.
Experimental design. We fed dams Teklad Global 18% Protein Rodent Diet 2018 until E9 and then fed Teklad Global 16% Protein Rodent Diet 2016 (both from Harlan Teklad, Madison, WI). On E12, we weighed the dams and randomly distributed them into eight groups (corn oil and TCDD groups at E15, E16, E17, and PND1); dams were treated by oral gavage with corn oil or a single dose of 10 μg TCDD in 110 μL corn oil/kg body weight. We harvested the embryos at E15, E16, and E17 and pups on PND1.
Transepidermal water loss (TEWL). We harvested embryos and PND1 pups and rinsed them twice in PBS, allowed them to air dry for 5 min, and measured TEWL (in grams per square meter per hour) at the dorsal posterior region using the Delfin VapoMeter with a 4.5mm nail adapter attached (Delfin Technologies Ltd, Stamford, CT).
Skin permeability assay. We performed an EPB assay using the βgalactosidase substrate 5bromo4chloro3indolyl βdgalactopyranoside (Xgal) according to a published method (Hardman et al. 1998) , as previously described (Sutter et al. 2011) . Briefly, the embryos and pups were incubated in the Xgal reaction mixture for 24 hr at room temperature, then fixed in 4% para formaldehyde at 4°C for 24 hr, and subse quently transferred to 70% alcohol. Digital images were quantified as described previously (Sutter et al. 2011) .
Histology. We fixed whole embryos or PND1 mice for 24 hr at 4°C in 4% para formaldehyde, pH 7.4, followed by 20% sucrose for 24 hr at 4°C. We embedded the fixed animals in optimal cutting tempera ture (OCT) medium (TissueTek; Sakura Finetek USA, Torrance, CA) and prepared a sagittal section of 10μm thickness using a microtome cryostat. We stained the sections with hematoxylin and eosin (H&E) reagents and visualized the sections using a Nikon Eclipse E800 microscope (Nikon, Melville, NY). For toluidine blue staining, an approxi mately 5mm piece of dorsal skin was fixed in 2.5% glutaraldehyde plus 2.5% para formal de hyde in 0.1 M sodium cacodylate buffer (pH 7.4) at 4°C. The samples were postfixed in 2% osmium in 0.1 M sodium cacodylate buffer (pH 7.4), embedded in Epon 812 (Polysciences, Warrington, PA), and cut in semi thin sections (800 nm) on an Ultracut E microtome (Reichert Technologies, Depew, NY). We applied filtered toluidine blue staining solution (0.5% toluidine blue plus 1% borax in deionized water) to dried semithin sections on a 60°C hot plate and stained them for 2 min, then rinsed the stained slides under running tap water. We cleared the sections by dipping them into a 95% acidalcohol solution (50 mL of 95% ethanol plus one drop of glacial acetic acid solution). We subsequently rinsed the slides under running tap water to remove excess acid alcohol and let the slides dry before mounting with CytosealXYL mounting medium (RichardAllan Scientific, Kalamazoo, MI). We evaluated the slides using a Nikon Eclipse E800 microscope.
Ultrathin section transmission electron microscopy (TEM). We cut tissue sections (50-70 nm) using an Ultra Cut UCT (Leica Mikrosysteme GmbH, Vienna, Austria) with a Diatome diamond knife (Electron Microscopy Sciences, Hattfield, PA). We mounted the cut sections on Formvar carbon-supported copper grids and air dried them in a clean, covered area. We stained the tissue sections with aqueous 4% uranyl acetate for 30 min at room temperature and rinsed them with deionized water. The moist grids were stained for 2 min with Reynold's Lead Citrate (Electron Microscopy Sciences), rinsed, and allowed to dry completely in a clean, covered area. We analyzed the dried grids with a Jeol 1200EX II TEM (Jeol USA Inc., Peabody, MA) using 60 KV or 80 KV.
Epidermal lipid analysis. We weighed whole embryos or PND1 pups and extracted the epidermal lipids in chloroform:methanol (1:2 vol/vol) by vortexing at moderate speed for 2 min. The organic phase was dried under liquid nitrogen, redissolved in chloroform:methanol (1:1), and analyzed by highperformance thinlayer chromatography (HPTLC) as previously described (Tran et al. 2012) .
TJ permeability assay. We analyzed TJ function according to a published method (Furuse et al. 2002) . We injected 50 μL of a 10mg/mL biotinSH (EZLink SulfoNHSLCBiotin; catalog no. 21335; ThermoScientific, Pittsburgh, PA) solution in PBS, pH 7.4, containing 1 mM calcium chloride into the dermis on the backs of PND1 pups. After a 30min incubation at room temperature, we cryopreserved the whole pups in OCT medium, and cryo sectioned sagittal sections (10 μm). We fixed the tissue sections in 95% ethanol at 4°C for 30 min, followed by 100% acetone at room temperature for 1 min. We incubated the tissues in 10% normal goat serum blocking solution for 30 min at room temperature, subsequently incubated them in claudin1 monoclonal antibody (1:200; catalog no. 519000; Invitrogen, Grand Island, NY) for 30 min, and washed them three times with PBS for 10 min each wash. The tissue sections were subsequently incubated in a solution of Alexa Fluor® 488 Goat AntiRabbit IgG (H+L) (1:2,000; catalog no. A11008; Invitrogen) and Streptavidin, Alexa Fluor® 568 conjugate (1:200; catalog no. S112260; Invitrogen) for 30 min, washed with PBS three times for 10 min each, mounted with ProLong® Gold Antifade Reagent with DAPI (catalog no. P36931; Invitrogen) and let cure overnight. We visualized the sections using a Nikon A1 laserscanning confocal micro scope. We counted claudin1-positive sites of the SG, with or without stops, for the diffu sion of biotinSH toward the skin surface. We counted at least three visual fields per sample, and analyzed a total of three pups from three different dams per treatment condition.
SC tape stripping. We euthanized PND1 pups as described above and measured TEWL after sequential tape stripping of the SC layers of the dorsal posterior skin using adhesive tape (catalog no. 159015R; 19 mm × 13 mm; ThermoScientific). We performed six tape strippings to remove most of the SC (Tsai et al. 1991) .
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Results
TCDD accelerates EPB formation and function. Previously, we reported that 3day in utero exposure to TCDD accelerated EPB formation in C57BL/6J mice by 1 day, beginning at E15 (Sutter et al. 2011) . In the present study, embryos were continuously exposed in utero to TCDD beginning on E12. Development of the EPB, measured as exclusion of an Xgal substrate of endogenous epidermal βgalactosidase, was accelerated by 1 day in TCDDexposed embryos, begin ning at E15 and continuing to E16. By E17 and continuing to PND1, we observed no differences between the control and TCDD exposed animals, with complete develop ment of the EPB by PND1 ( Figure 1A,B) . To evaluate the integrity of EPB function, we measured TEWL in the dorsal posterior region of the embryos and PND1 pups. TEWL readings were significantly lower in the TCDDexposed mice at E16, E17, and PND1 compared with their agematched cornoil controls ( Figure 1C ), indicating that in utero exposure to TCDD significantly accelerated the function of the EPB.
TCDD exposure results in epidermal acanthosis and hyperkeratosis. Topical appli cation of TCDD on hairless mice skin has been reported to cause epidermal hyperplasia (Puhvel and Sakamoto 1988) . However, Loertscher et al. (2002) previously reported that in utero exposure of C57BL/6J embryos to TCDD did not alter the histology of the skin. Contrary to Loertscher et al. (2002) , histology with H&E and toluidine blue staining indicated that TCDD was associ ated with an early onset of epidermal hyper plasia beginning at E15 (Figure 2A,B) . Significant thickening of the epidermis was observed at E16 and PND1 (Figure 2A ,B, doubleheaded arrows; Figure 2C ), indicating epidermal acanthosis in response to exposure to TCDD. Similarly, the SC was readily apparent in TCDDexposed embryos as early as E16 (Figure 2A,B) , and measurement of the SC at PND1 revealed that this layer was about twice as thick in the TCDDexposed pups compared with their cornoil controls ( Figure 2D ). The observed thickening of the SC in TCDDexposed mice is indicative of a pronounced epidermal hyperkeratosis. Enhanced thickening of the epidermis and SC by TCDD was confirmed using ultrathin section TEM ( Figure 2E ). Significant thick ening of the SC was not due to an increase in the number of SC layers because the number of SC layers-approximately 10-12 layers-was similar in the cornoil control and TCDDexposed mice.
TCDD increases epidermal ceramide levels. The lipidenriched matrix of the SC is composed of cholesterol, free fatty acids, and ceramides. Ceramides are the predominant lipids in the SC (Uchida and Holleran 2008) . In cultures of normal human epidermal keratinocytes, we have observed increases in several classes of ceramides, without changes in cholesterol or free fatty acids (Kennedy et al. 2013 ). Here, we investigated whether TCDD altered the composition of lipids in developing murine skin. We extracted epidermal lipids and separated them by HPTLC ( Figure 3A) , with assignments based on standards and our previous analyses (Kennedy et al. 2013; Tran et al. 2012) . The levels of shortchain ceramides (NS and NH) and the ceramide precursors acylglucosyl ceramide (acylGC) and glucosyl ceramide (GC) were increased in TCDDexposed embryos at E15 (Figure 3B ). At E16, levels of acylGC and GC were similar in the control and TCDDexposed mice. However, addi tional shortchain ceramides (NS, NP, AS, and NH) and the longchain ceramide (EOP) were elevated in the TCDDexposed embryos ( Figure 3B ). At E17 and PND1, ceramide levels were similar in the control and TCDD samples. Given that ceramides are important components of the SC, the observed eleva tion of ceramides at E15 and E16 might be a contributing factor to the accelerated barrier formation and function observed in the in utero TCDDexposed mice (Figure 1 ). The levels of cholesterol and free fatty acids were unaffected by TCDD, consistent with what we previously observed in human keratino cytes (Kennedy et al. 2013) .
In utero exposure to TCDD disrupts TJ function in PND1 pups. In addition to the SC, TJs of the lateral membrane of the SG contribute to the paracellular waterand ion barrier that is essential to EPB function (Furuse et al. 2002) . Because of the impor tance of these TJs to the EPB, we investi gated whether in utero exposure to TCDD altered this function. We injected biotinSH dye into the dermis of PND1 mice and monitored the diffusion of this dye from the dermis through the epidermis, quan tifying whether the biotinSH dye crossed or stopped at the claudin1-staining TJs located in the apical region of the SG. We examined terminal TJs for biotinSH stop or leakage sites by colocalization ( Figure 4A , composite) of claudin1 ( Figure 4A , green) and biotinSH dye ( Figure 4A , red). In the control pups, biotinSH dye stopped at > 60% of the claudin1-staining TJs. In the TCDDexposed pups, nearly 80% of these TJs had leaks for biotinSH ( Figure 4B ), indicating that TCDD is disrupting the TJ barrier function. To understand why TCDDexposed mice with disrupted TJ barrier showed significantly lower TEWL ( Figure 1C )-which is contrary to what was expected-we investigated the idea that the observed hyperkeratosis in the TCDD exposed mice compensated for the leaky TJs, thus diminishing water loss in this abnormal EPB. In order to test this hypothesis, we performed six sequential tape strippings of the dorsal posterior skin of control and TCDD exposed PND1 mice to remove most of the SC. Our data indicate that the removal of the SC resulted in a significant increase in TEWL in the TCDDexposed mice compared with their agematched tapestripped controls ( Figure 4C ). This result is consistent with the idea that the thick SC layer in TCDD exposed murine skin acts to prevent water loss, even in the presence of a disrupted TJ barrier.
Discussion
The epidermis serves as the first line of defense and protection against environmental pathogens, allergens, and toxins, as well as preventing the loss of water and ions. In mice, formation of the EPB begins at E16 and is completed by E17.5. We previously reported that TCDD accelerated the timing of EPB formation in C57BL/6J mice starting at E15 (Sutter et al. 2011) . Here, we confirm our previously published data and also report that, at E17, barrier formation is completed in C57B/6J embryos exposed in utero to TCDD or corn oil. The SC, with its corneocytes and lipid matrix and the TJs of the SG constitute the 
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De Benedetto et al. 2012) , and a few studies of TCDD have shown that exposure to this environmental pollutant exacerbates atopic diseases in an animal model (Ito et al. 2008) and in humans (Kim et al. 2003; Kimata 2003) . Mice expressing a keratin 14-driven constitutively active AHR exhibit skin lesions with itching that are consistent with atopic dermatitis (Tauchi et al. 2005) , and one study of Korean Vietnam veterans reported a statisti cally significant association between the inci dence of eczema and Agent Orange exposure (Kim et al. 2003) . Nonetheless, the role of TCDD in the causation of atopic dermatitis remains controversial. Whereas some studies have found that TCDD exacerbates atopic dermatitis in NC/Nga mice (Ito et al. 2008) , increases IgE production in B cells from patients with atopic diseases (Kimata 2003) , and disrupts mucosal immunity in the gut and sensitizes C57BL/6J mice to oral allergens (Kinoshita et al. 2006) , other studies have reported that exposure to TCDD suppressed allergic immune response to ovalbumin, dust, and peanuts in laboratory animals (Luebke et al. 2001; Schulz et al. 2011; Tarkowski et al. 2010 ) and failed to induce atopic derma titis in NC/Nga mice (Fujimaki et al. 2002) . Of interest, all of these studies of TCDD and atopic disease have focused on the immu nological responses occurring after TCDD exposure. Although the immune component of atopic disease should not be understated, the emerging understanding of the role of a defective EPB as an underlying cause of several atopic diseases (Boguniewicz and Leung 2011; De Benedetto et al. 2012; Proksch et al. 2008) indicates the need for further study of this important aspect of biology. For example, it is now understood that a compromised EPB is required for allergens to enter the epidermis and elicit inflamma tory or hypersensitive reactions (Boguniewicz and Leung 2011; De Benedetto et al. 2012 ).
In addition, lossoffunction mutations in the filaggrin gene have been identified as a major pre disposing factor for atopic dermatitis (Palmer et al. 2006) . Also of interest, albeit from a therapeutic perspective, van den Bogaard et al. (2013) recently reported that activation of the AHR by coal tar in a submerged culture of human keratinocytes and human organotypic skin from patients with atopic dermatitis enhanced epidermal differentiation and thickening of the SC in the skin equivalents; in biopsies from patients treated with coal tar, the expression of filaggrin and other markers of differentiation were increased. Whether these potentially beneficial effects of coal tar will be limited to atopic dermatitis asso ciated with filaggrin mutations or whether AHR activation may provide general benefit to this inflammatory skin disease is currently unknown. Similarly, whether the difference in perspective (i.e., therapeutic vs. toxic) between van den Bogaard et al. (2013) and the work presented here represents differences between adult and perinatal exposure, differ ences between mice and humans, or differ ences between longacting ligands such as TCDD and shorteracting, metabolized AHR agonists, such as polycyclic aromatic hydro carbons, remains unknown. Finally, the effects reported by van den Bogaard (2013) did not consider additional aspects of the EPB such at the TJ and lipid components. Nonetheless, because of the importance of both develop mental susceptibility and the need for mechanismbased treatments for inflamma tory skin disease, all of these questions and their answers require further elaboration.
Conclusions
We found that the timing of the formation of an abnormal EPB was accelerated after in utero exposure to TCDD. The histo pathology of this abnormal barrier was char acterized by acanthosis and hyperkeratosis. Moreover, TCDD disrupted the TJ function of the epidermis. Tape stripping of control and TCDDexposed mice indicated that epidermal hyperkeratosis compensated for excessive TEWL from the disrupted barrier. These results indicate that TCDD has the potential to a) induce or exacerbate cutaneous Quantification of claudin-positive sites for terminal TJs without biotin-SH stops (≥ 3 visual fields per sample were counted, and 3 pups per treatment condition were analyzed). A total of 87 terminal TJs were counted in corn-oil samples; 30 of these terminal TJs had leaks for biotin-SH. In TCDD-exposed pups, 104 terminal TJs were counted, and 72 of these terminal TJs had leaks for biotin-SH. (C) TEWL after SC removal in PND1 mice. The dorsal skin of mice was tape stripped six times to remove most of the SC before TEWL was measured. At least 22 pups from 4 dams were assayed in the control or TCDD-exposed group. Values are means ± SDs. *p < 0.05, compared with age-matched control samples by Student's t-test. EPB function of the epidermis. Ceramides are the major lipid component in the lipid matrix of the SC. Microarray and lipid analyses previously published by our labora tory showed that the expression of approxi mately 75% of genes involved in de novo ceramide biosynthesis, as well as the levels of eight classes of ceramides, were increased in TCDDexposed human keratinocytes (Kennedy et al. 2013) . In the present develop mental animal study, we found that the accelerated barrier formation by TCDD at E15 is associated with an increased accu mulation of the ceramide precursors acylGC and GC as well as the shortchain ceramides NS and NH. At E16, we observed elevated levels of shortchain (NS, NP, AS, and NH) and longchain (EOP) ceramides in TCDD exposed embryos, which corresponded with the accelerated formation and function of the EPB to exclude Xgal. However, elevated levels of ceramides at E15 and E16 were not accompanied by increases in cholesterol or free fatty acids. This imbalanced ratio of ceramide to free fatty acids and cholesterol might affect lamellar body formation and alter barrier homeostasis. Such alterations of skin lipids have been implicated in skin disorders such as lamellar ichthyosis (Feingold 2007; Schmuth et al. 2001; Uchida and Holleran 2008) .
Exposure to TCDD has been reported to cause chloracne in humans (Panteleyev and Bickers 2006) , and limited animal studies have reported that topical applica tion of TCDD on hairless mice resulted in thickening of the epidermis (acanthosis) and SC (hyperkeratosis) (Panteleyev et al. 1997; Puhvel and Sakamoto 1988) . In one study, Loertscher et al. (2002) reported that in utero TCDD exposure did not alter the normal epidermal morphogenesis even though they observed premature expression of filaggrin at E16. However, in the present study, we found that in utero TCDD exposure altered the histology of the epidermis, resulting in epidermal hyperplasia beginning at E15. Thickening of the epidermis was observed in the TCDDexposed embryos and PND1 pups. In addition, significant epidermal hyperkeratosis was observed at PND1. Our data clearly indicate abnormal, but acceler ated, EPB formation after in utero TCDD exposure. Epidermal acanthosis and hyper keratosis are histopathological characteristics that are commonly observed in chloracne (Panteleyev and Bickers 2006) and epidermo lytic hyperkeratosis, a genetic disorder asso ciated with keratin mutations (Müller et al. 2006; Reichelt et al. 1999) . The SC and TJs provide the physical barrier components of the epidermis. Disruption of the integrity of the SC or TJ barrier impairs the normal functioning of the EPB. Using a biotinSH TJ assay we showed that TCDD can disrupt the TJ barrier in PND1 pups, resulting in the leakage of the dye across the TJs. Several animal studies have reported that mice with defective TJs have compromised EPB function and show enhanced TEWL (Furuse et al. 2002; Sugawara et al. 2013; Tunggal et al. 2005; Turksen and Troy 2002) . Contrary to these reports, in the present study we observed that TCDDexposed embryos showed unexpectedly lower rates of TEWL from E16 to PND1, suggesting that there might be a compensatory mecha nism preventing excessive water loss via the defective TJ barrier. Kuramoto et al. (2002) previously reported that grafted mature trans glutaminase 1 (TGase1)-deficient murine skin with remarkable epidermal hyperplasia and hyperkeratosis showed lower TEWL, similar to control TGase1proficient mice. However, removal of the thick epidermal hyperkeratosis resulted in an increase in TEWL (Kuramoto et al. 2002) . In a similar light, we report here that removal of the SC by tape stripping resulted in a significant increase in TEWL in the TCDDexposed pups compared with the cornoil control pups. Thus, the observed hyperkeratosis in TCDDexposed pups may act to compensate for the disrupted TJ component of the EPB.
In addition to the SC, TJs contribute to the paracellular waterandion barrier that is present in the SG. Disruption of the TJ barrier has been linked to atopic diseases in humans (Boguniewicz and Leung 2011; 
